Withholding versus continuing angiotensin-converting enzyme inhibitors
or angiotensin II receptor blockers before noncardiac surgery: an analysis of the Vascular Events in Noncardiac Surgery Patients Cohort Evaluation prospective cohort.
The use of beta-blockers and angiotensin-converting enzyme inhibitors
was done and good clinical response was observed to make hospital discharge possible.
Macpherson, "Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors
: How much should we worry?" JAMA Internal Medicine, vol.
Angiotensin-converting enzyme inhibitors
reduce mortality in hypertension: A meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.
Lillienfeld, "Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors
," Hypertension, vol.
Neuroprotective effects of antihypertensive medication are achieved by angiotensin-converting enzyme inhibitors
and diuretics, according to some authors (3), but also by angiotensin II receptor antagonists and dihydropiridines, according to other authors (4).
Angioedema induced by angiotensin-converting enzyme inhibitors
. Curr Opin Allergy Clin Immunol.
An evaluation of risk factors foe adverse drug events associated with angiotensin-converting enzyme inhibitors
. J Eval Clin Pract.
Reinecke, "Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors
or AT-1 blockers on frequency of contrast medium-induced nephropathy: a posthoc analysis from the Dialysis-versus-Diuresis (DVD) trial," Nephrology Dialysis Transplantation, vol.
Reasons for underuse of angiotensin-converting enzyme inhibitors
in patients with heart failure and left ventricular dysfunction.
Correction page 245-250/Duzeltme sayfa 245-250: The effects of chronic usage of angiotensin-converting enzyme inhibitors
and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients Nezihi Baris, Ebru Ozpelit, Nazile Bilgin Dogan, Hande Kangul, Sefa Gul, Bahri Akdeniz, Sema Guneri
Acute hypotensive transfusion reaction with concomitant use of angiotensin-converting enzyme inhibitors
: a case report and review of the literature.
Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors
, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated.
The seven measures assessed included: three types of heart failure medications, including beta blockers, aldosterone antagonists, and angiotensin-converting enzyme inhibitors
or angiotensin receptor blockers; the use of cardiac resynchronization therapy, a device that helps coordinate heart contractions; anticoagulant therapy for atrial fibrillation; the use of an implantable cardioverter-defibrillator device; and heart-failure patient education.
In both study groups, additional antihypertensive drug treatment, other than ARBs or angiotensin-converting enzyme inhibitors
, was used to reach the target blood pressure of less than 130/80 mm Hg, Dr.